We are live on
!
Find out more
HEC
Hudson Executive Capital Portfolio holdings
AUM
$151M
1-Year Est. Return
60.14%
This Fund
S&P 500
This Quarter
Est. Return
+15.69%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$1.08B
AUM Growth
+$87.4M
(+8.8%)
Cap. Flow
-$18.5M
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
2
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
|
+$4.01M |
| 2 |
CTLP
Cantaloupe
CTLP
|
+$3.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
THS
Treehouse Foods
THS
|
+$125M |
| 2 |
AtriCure
ATRC
|
+$26.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 49.02% |
| 2 | Industrials | 26.83% |
| 3 | Healthcare | 7.96% |
| 4 | Real Estate | 2.77% |
| 5 | Technology | 1.14% |
Similar funds
SHF
CCM
DIG
BDS
MWA
WBCM
CAM
BA
Hudson Executive Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Hudson Executive Capital held 11 positions worth $1.08B, up 8.8% from $990M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hudson Executive Capital's Q1 2019 filing shows 2 new, 2 increased, 1 reduced and 2 closed positions. The largest sale was Treehouse Foods, an estimated $125M.
By sector, the portfolio is most concentrated in Financials at 49% of assets, down from 53% a quarter earlier, followed by Industrials and Healthcare.
- Hudson Executive Capital added most to CORINDUS VASCULAR ROBOTICS, INC in Q1 2019, an estimated $4.01M increase.
- Hudson Executive Capital's biggest Q1 2019 reduction was AtriCure, cutting an estimated $26.8M.
- Hudson Executive Capital fully exited Treehouse Foods in Q1 2019, selling an estimated $125M.
- Hudson Executive Capital's ten largest holdings make up 100% of its $1.08B portfolio in Q1 2019.
- Hudson Executive Capital opened 2 new positions and closed 2 in Q1 2019.
- Hudson Executive Capital's portfolio value rose 8.8% quarter-over-quarter to $1.08B.
Based on Hudson Executive Capital's 13F filing for Q1 2019, filed 15 May 2019.